Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
cabergoline, Quantity: 500 microgram
Arrotex Pharmaceuticals Pty Ltd
Cabergoline
Tablet
Excipient Ingredients: lactose; magnesium stearate
Oral
8 tablets, 2 tablets
(S4) Prescription Only Medicine
? Inhibition of physiological lactation ,Cabergoline is indicated for the prevention of the onset of physiological lactation in the puerperium for clearly defined medical reasons. ,? Treatment of hyperprolactinaemic disorders ,Cabergoline is indicated for the treatment of pathological hyperprolactinaemia.
Visual Identification: White coloured, capsule shaped, flat, scored tablets with debossed "APO" on one side and "CA" bisect "0.5" on the other side.; Container Type: Bottle; Container Material: Glass Type III Coloured; Container Life Time: 21 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure
Licence status A
2015-11-20